FDA December 2024 PCAC Review - Compounding Prohibited In December 2024, the U.S
23 Supplementation of 1 mg daily is recommended for patients with specific risk factors (e.g., bariatric/gastric surgery patients, those with severe malnutrition, chronic alcohol use, chronic hemolytic anemia and conditions with high cell turnover, and use of antimetabolite medications such as methotrexate)
Biological Activity In animal models, 5-Amino-1MQ markedly reduces body weight and fat mass, improves insulin sensitivity, and reverses diet-induced hepatic steatosis and adiposity 2,3
Diabetics who take metformin may have low B12 levels as a side effect of the drug
Customer service is aslo omn another level, 100% buying again katie steele Verified buyer best company in canada